GMFG expression in breast cancer tissues was analyzed using Polyclonal Anti-GMFB antibody

Glia maturation factor gamma (GMFG) in breast cancer.
Triple-negative breast cancer (TNBC) has a poor prognosis due to the lack of established targeted treatment options.

The Glia Maturation Factor gamma (GMFG), a novel ADF/cofilin superfamily protein, has been reported to be differentially expressed in tumors, but its expression level in TNBC remains unknown.

A new study analyzed the expression of GMFG in pan-cancer and the correlation between clinical factors. The data were pulled from different databases, including the Human Protein Atlas.

🔬GMFG expression in breast cancer tissues was also analyzed by immunohistochemistry (IHC) using our Polyclonal Anti-GMFB antibody (HPA002954).

👉 The results indicate that high expression of GMFG in triple-negative breast cancer is related to malignancy and that GMFG could be a biomarker for detecting triple-negative breast cancer metastasis.

The image from Zhao et al. (Genes 2023) shows GMFG protein levels (medium in normal tissue and low in tumor cells).

Read the full article: https://lnkd.in/gNw9U6zc